阅读说明：本技术 5-甲基-1,3,4-噁二唑-2-基化合物 (5-methyl-1, 3, 4-oxadiazol-2-yl compounds ) 是由 N·J·F·德雷福斯 P·J·林赛-斯科特 R·E·拉斯梅尔 于 2018-05-18 设计创作，主要内容包括：本发明提供了式I化合物或其可药用盐,以及式I化合物用于治疗神经变性疾病和病症例如阿尔茨海默氏病的用途。<Image he="232" wi="700" file="DDA0002282342280000011.GIF" imgContent="drawing" imgFormat="GIF" orientation="portrait" inline="no"></Image>(The present invention provides compounds of formula I or pharmaceutically acceptable salts thereof, and the use of compounds of formula I for the treatment of neurodegenerative diseases and disorders such as Alzheimer's disease.)